Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 12:23
Narrative updating · score is newerEvidence Synthesis
THYROCARE's 54.0% gross margin accelerated to, up from 27.4% previously.
The company's .4% marginal operating leverage also accelerated to, up from .67% previously.
In terms of revenue growth, THYROCARE's .7% decelerated from .3% previously. The company's daily volume decreased by 22.7% to to .
The stock's close price accelerated by 2.9% to .55 INR, up from .7 INR previously.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 54 % | 27.4 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 27.4 % | 19.67 | ▲ |
| REVENUE_GROWTH_YOY | 19.7 % | 116.3 | ▼ |
| EPS_ACTUAL | 2.443 INR | 2.115 | ▲ |
| EPS_SURPRISE_PERCENT | 0.437 % | 0.113 | ▲ |
| PRICE_CHANGE_PERCENT | 2.655 % | — | - |
| DAILY_VOLUME | 1,85,788 shares | 5,52,939 | ▼ |
| CLOSE_PRICE | 535.55 INR | 521.7 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 5 | ▼ |
| TARGET_PRICE_PREMIUM | 12.59 % | — | - |